AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29074303
Drug: dexmedetomidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexmedetomidine (1 μg kg−1, PLD)
Trial: 29074303
Drug: dexmedetomidine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexmedetomidine (2 μg kg−1, PHD)
Trial: 26446165
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg intravenous bolus of methylprednisolone
Trial: 17274922
Drug: Tamoxifen for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen for 2.5 years followed by aromatase inhibitor for 2.5 years
Trial: 17274922
Drug: 5 years
RxNorm normalized name: Dymadon 5 Years Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 years of aromatase inhibitor
Trial: 15265851
Drug: Vitamin K2
RxNorm normalized name: Vitamin K2
DrugBank: Menaquinone 6 (DB14936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K2 (menaquinone) 45 mg/d
Trial: 15265851
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (symptomatic therapy for ascites and dietary advice)
Trial: 791586
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg azapropazone daily for 2 weeks
Trial: 791586
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg naproxen daily for 2 weeks
Trial: 30847805
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide extended-release (ER) 32 mg (Zilretta®)
Trial: 30847805
Drug: Repeat administration
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeat administration of triamcinolone acetonide ER
Trial: 30847805
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide crystalline suspension (CS)
Trial: 19144173
Drug: Long-acting bronchodilators
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting bronchodilators alone
Trial: 19144173
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids and combination treatment
Trial: 17461719
Drug: lopinavir/ritonavir 400/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lopinavir/ritonavir 400/100 mg twice-daily or 800/200 mg once-daily with gastric acid-reducing agents
Trial: 17461719
Drug: lopinavir/ritonavir 400/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lopinavir/ritonavir 400/100 mg twice-daily or 800/200 mg once-daily without gastric acid-reducing agents
Trial: 15610362
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose birch pollen exposure during pregnancy
Trial: 15610362
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose birch pollen exposure during pregnancy
Trial: 11310807
Drug: Amoxicillin-clavulanate (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanate (2 g/200 mg/8 hr)
Trial: 11310807
Drug: Ceftriaxone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (1 g/24 hr)
Trial: 8389105
Drug: ICI 204,219
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICI 204,219 (200 micrograms/puff, total dose 1,600 micrograms)
Trial: 27472878
Drug: Crocus sativus
RxNorm normalized name: CROCUS SATIVUS WHOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crocus sativus L.
Trial: 22325963
Drug: Multimodal periarticular
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multimodal periarticular soft tissue injection
Trial: 17280925
Drug: 0.4 ml
RxNorm normalized name: ethanol 0.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 ml fentanyl 0.05 mg/ml
Trial: 17280925
Drug: 0.4 ml
RxNorm normalized name: ethanol 0.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 ml mepivacaine with epinephrine 1:200,000
Trial: 15663351
Drug: Rasagiline 1
RxNorm normalized name: rasagiline 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline 1 or 2mg once daily
Trial: 15663351
Drug: Rasagiline 0.5
RxNorm normalized name: rasagiline 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline 0.5 or 1mg once daily
Trial: 15663351
Drug: Rasagiline 1mg
RxNorm normalized name: Rasagiline 1mg Oral tablet
DrugBank: Rasagiline (DB01367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Rasagiline 1mg once daily
Trial: 15663351
Drug: Rasagiline (monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline (monotherapy and combination therapy)
Trial: 9988823
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (15 mg)
Trial: 1575174
Drug: Nifedipine SR
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine SR 50 mg
Trial: 1575174
Drug: Nifedipine SR
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine SR 100 mg
Trial: 1575174
Drug: Nifedipine SR
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine SR 150 mg
Trial: 30169375
Drug: Concurrent pictorial
RxNorm normalized name: influenza B virus B/Victoria/705/2018 antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent pictorial drug choice task (smoking vs. not smoking)
Trial: 30169375
Drug: Concurrent pictorial
RxNorm normalized name: influenza B virus B/Victoria/705/2018 antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent pictorial drug choice task (alcohol vs. food)
Trial: 18773262
Drug: 0.25% nipradilol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% nipradilol, twice daily for 3 years
Trial: 18773262
Drug: 0.5% timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% timolol ophthalmic solution, twice daily for 3 years
Trial: 14669936
Drug: Antioxidant vitamin
RxNorm normalized name: antioxidant vitamins with minerals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant vitamin supplement (18 mg beta‐carotene, 900 mg vitamin C, 90 mg vitamin E)
Trial: 14669936
Drug: Antioxidant vitamin
RxNorm normalized name: antioxidant vitamins with minerals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant vitamin supplement
Trial: 8705154
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg intra-articular morphine in 15 ml isotonic saline
Trial: 8705154
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg intravenous morphine in 10 ml isotonic saline
Trial: 2371491
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 500 mg/day for 3 days
Trial: 22420837
Drug: Conventional antiseptic
RxNorm normalized name: Listerine Antiseptic
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional antiseptic (polyhexanide solution) dressings
Trial: 19486346
Drug: m-TOR inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: m-TOR inhibitor sirolimus (SRL)
Trial: 16855426
Drug: Rotigotine transdermal
RxNorm normalized name: Rotigotine Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotigotine transdermal patch (4 mg/24 h starting dose, increased by 4 mg/24 h weekly)
Trial: 16855426
Drug: Rotigotine transdermal
RxNorm normalized name: Rotigotine Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotigotine transdermal patch (4 mg/24 h starting dose, increased by 2 mg/24 h weekly)
Trial: 16855426
Drug: Fast-titration regimen
RxNorm normalized name: Anacin Aspirin Regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast-titration regimen of rotigotine
Trial: 16855426
Drug: Slow-titration regimen
RxNorm normalized name: Slow-Fe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-titration regimen of rotigotine
Trial: 12944032
Drug: Nisoldipine ER
RxNorm normalized name: nisoldipine Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine ER (20 to 60 mg once daily)
Trial: 12944032
Drug: Amlodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5 to 10 mg once daily)
Trial: 9088588
Drug: Itraconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (200 mg twice daily for 14 days)
Trial: 8491252
Drug: Atenolol 150
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol 150 mg
Trial: 26322917
Drug: Omega 3
RxNorm normalized name: omega 3,6
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omega 3 fatty acid (O3FA) oral supplement (2,400 mg/day) for 45 days
Trial: 26322917
Drug: Placebo (olive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (olive oil, 8 capsules)
Trial: 23695483
Drug: Escitalopram (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (5 mg/d titrated to 20 mg/d over 6 weeks)
Trial: 18261166
Drug: EPA (eicosapentaenoic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA (eicosapentaenoic acid) 1800 mg daily from day 4 to day 14
Trial: 16173532
Drug: External Qi
RxNorm normalized name: San Qi Root
DrugBank: Panax notoginseng root (DB14304)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External Qi therapy (EQT)
Trial: 12921918
Drug: Selegiline 5
RxNorm normalized name: selegiline 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline 5 mg/day (under 5 years) and 10 mg/day (over 5 years)
Trial: 21416235
Drug: Methylphenidate 1
RxNorm normalized name: methylphenidate 17.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate 1 mg/kg/day
Trial: 10937097
Drug: Carbon dioxide
RxNorm normalized name: Carbon Dioxide
DrugBank: Carbon dioxide (DB09157)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbon dioxide laser treatment alone
Trial: 10937097
Drug: Carbon dioxide
RxNorm normalized name: Carbon Dioxide
DrugBank: Carbon dioxide (DB09157)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbon dioxide laser treatment followed by erbium:YAG laser treatment
Trial: 10937097
Drug: Erbium:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erbium:YAG laser treatment alone
Trial: 10937097
Drug: Erbium:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erbium:YAG laser treatment followed by carbon dioxide laser treatment
Trial: 10937097
Drug: Untreated skin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Untreated skin subjected to laser treatment
Trial: 8669575
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml bupivacaine 0.5% + 25 mg (0.5 ml) ketamine + 1 in 200,000 adrenaline
Trial: 8669575
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml bupivacaine 0.5% + 0.5 ml 0.9% saline + 1 in 200,000 adrenaline
Trial: 6721765
Drug: Half-strength povidone-iodine
RxNorm normalized name: Povidone-Iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Half-strength povidone-iodine (Betadine) solution
Trial: 11531671
Drug: 5000 U
RxNorm normalized name: lipase 5000 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5000 U unfractionated heparin subcutaneously after surgery
Trial: 11531671
Drug: 7500 U
RxNorm normalized name: amylase 97500 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7500 U unfractionated heparin subcutaneously after surgery
Trial: 11531671
Drug: 10,000 U
RxNorm normalized name: Erwinaze 10,000 UNT Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10,000 U unfractionated heparin subcutaneously after surgery
Trial: 7985709
Drug: Low-dose amphotericin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose amphotericin B (0.1 mg/kg per day)
Trial: 29208686
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) administration (20 μg/kg sc 3×/week) for 26 weeks
Trial: 24693681
Drug: Antioxidant nutrients
RxNorm normalized name: CertaVite Senior with Antioxidant Nutrients Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant nutrients supplement (AO) for 5 days prior to surgery
Trial: 24693681
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CT) with no supplement
Trial: 19546522
Drug: Ciclosporine (CsA)
RxNorm normalized name: ciclosporin
DrugBank: Cyclosporine (DB00091)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ciclosporine (CsA) 2.5 mg/kg body weight
Trial: 10535855
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) 2 g daily
Trial: 15474755
Drug: CE/MPA (conjugated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CE/MPA (conjugated estrogen 0.625 mg + medroxyprogesterone acetate 5 mg)
Trial: 15474755
Drug: E2/NETA (17‐beta‐estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2/NETA (17‐beta‐estradiol 2 mg + norethisterone acetate 1 mg)
Trial: 2436359
Drug: Glycerol therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerol therapy
Trial: 2436359
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of glycerol and dextran
Trial: 28826262
Drug: Topical propolis
RxNorm normalized name: propolis
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical propolis ointment (5%; twice daily)
Trial: 28826262
Drug: Conventional therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapies alone
Trial: 24841843
Drug: Cocaine exposure
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine exposure (40 mg, IV)
Trial: 17418537
Drug: 5HT2 receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5HT2 receptor antagonists (trazodone or nefazodone)
Trial: 8666860
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg aerosolized pentamidine (AP) once-monthly
Trial: 8666860
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg aerosolized pentamidine (AP) twice-monthly
Trial: 2134327
Drug: IdB 1027
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IdB 1027 (600 mg b.i.d.) for 10 days
Trial: 474432
Drug: Intravenous disopyramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous disopyramide
Trial: 54578
Drug: Oral disopyramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral disopyramide
Trial: 30892810
Drug: 2RDA (1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2RDA (1.6 g kg‐1 day‐1)
Trial: 30892810
Drug: RDA (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RDA (0.8 g kg‐1 day‐1)
Trial: 25794201
Drug: Ultrasound-guided greater
RxNorm normalized name: greater celandine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided greater occipital nerve block (GONB) with bupivacaine 0.5% (1.5 mL)
Trial: 25794201
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline 0.9% 1.5 mL)
Trial: 24437202
Drug: Ozonotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozonotherapy and klimadynon (herbal medicine with estrogen-like action)
Trial: 21719111
Drug: Adjunctive clonazepam
RxNorm normalized name: Clonazepam
DrugBank: Clonazepam (DB01068)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjunctive clonazepam
Trial: 19301038
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (CaCO3) therapy
Trial: 19301038
Drug: Sevelamer therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevelamer therapy
Trial: 10570386
Drug: Low-dose narrow-band
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose narrow-band UVB phototherapy with calcipotriol ointment (50 microg/g) applied twice daily
Trial: 10570386
Drug: Low-dose narrow-band
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose narrow-band UVB phototherapy without calcipotriol ointment
Trial: 8673999
Drug: Adoptive immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adoptive immunotherapy (AI) with tumor-infiltrating lymphocytes (TIL) and recombinant interleukin-2 (rIL-2)
Trial: 8673999
Drug: Adoptive immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adoptive immunotherapy (AI)
Trial: 1651060
Drug: Pentostam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentostam (20 mg Sb/kg/day intramuscularly for 20 days)
Trial: 1651060
Drug: Allopurinol ribonucleoside
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol ribonucleoside (1,500 mg QID) plus probenecid (500 mg QID) for 28 days
Trial: 25669614
Drug: L-Polamidon® 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-Polamidon® 5 mg tablets (test)
Trial: 25669614
Drug: L-Polamidon® solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-Polamidon® solution for substitution (reference)
Trial: 21898754
Drug: Oral anti-diabetes
RxNorm normalized name: Diabetic Tussin EX Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anti-diabetes drugs + basal insulin
Trial: 21898754
Drug: Oral anti-diabetes
RxNorm normalized name: Diabetic Tussin EX Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anti-diabetes drugs alone
Trial: 18977068
Drug: Pitavastatin (P)
RxNorm normalized name: Pitavastatin
DrugBank: Pitavastatin (DB08860)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pitavastatin (P) therapy
Trial: 7619664
Drug: desipramine 100
RxNorm normalized name: desipramine 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: desipramine 100 mg
Trial: 7619664
Drug: reboxetine 4
RxNorm normalized name: reboxetine 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: reboxetine 4 mg
Trial: 2228340
Drug: Digoxin (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin (mean maintenance daily dose of 0.30 +/- 0.03 mg)
Trial: 154426
Drug: Oxamethacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxamethacin (100 mg b.i.d.)
Trial: 30573506
Drug: Mogamulizumab 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mogamulizumab 1.0 mg/kg once weekly for 4 weeks and biweekly thereafter
Trial: 30573506
Drug: Investigator's choice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigator's choice of chemotherapy
Trial: 25782428
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g low-fat milk powder (active control group)
Trial: 23562197
Drug: MFNS +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MFNS + OXY3 (200 μg MFNS q.d. + 3 sprays/nostril of OXY 0.05%)
Trial: 23562197
Drug: MFNS +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MFNS + OXY1 (200 μg MFNS q.d. + 1 spray/nostril of OXY)
Trial: 18924387
Drug: Complementary and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complementary and alternative therapies
Trial: 15226336
Drug: High-dose cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cisplatin (HDPEB) 40 mg/m² on days 1 through 5
Trial: 15226336
Drug: Standard-dose cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose cisplatin (PEB) 20 mg/m² on days 1 through 5
Trial: 15226336
Drug: High-dose cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cisplatin (HDPEB)
Trial: 15226336
Drug: Standard-dose cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose cisplatin (PEB)
Trial: 27196121
Drug: Intranasal dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal dexmedetomidine (1 μg∙kg‐1)
Trial: 22614545
Drug: Sustained-release bupropion
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release bupropion (Bup-SR) for 8 weeks
Trial: 18349557
Drug: Standard 1-week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard 1-week triple therapy followed by omeprazole (20 mg, qd) for 3 weeks (group A)
Trial: 18349557
Drug: Standard 1-week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard 1-week triple therapy only (group B)
Trial: 18349557
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg, qd) for 3 weeks followed by 1-week triple therapy (group C)
Trial: 14696468
Drug: Low-dose anticancer
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose anticancer drugs (Group A, n = 40)
Trial: 14696468
Drug: Conventional-dose anticancer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional-dose anticancer drugs (Group B, n = 42)